Assessing the appropriateness of paediatric antibiotic overuse in Australian children: a population-based sample

Gaston Arnolda1, Peter Hibbert1,2, Hsuen P Ting1

  • 1Australian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, North Ryde, New South Wales, 2109, Australia.

BMC Pediatrics
|April 26, 2020
PubMed

Insights

Antibiotic overuse in children is a concern. This study identified key indicators for monitoring and improving antibiotic prescribing in pediatric care, highlighting areas needing attention.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial stewardship
  • Clinical practice guideline adherence

Background:

  • Rising antibiotic resistance poses a significant public health threat.
  • Antibiotic overuse in pediatric populations is a major contributing factor to resistance.
  • Effective antimicrobial stewardship programs are crucial for combating resistance.

Purpose of the Study:

  • To analyze pediatric antibiotic overuse indicators in Australia.
  • To identify priority areas for antimicrobial stewardship and clinical improvement programs.
  • To assess adherence to clinical practice guidelines for 17 common childhood conditions.

Main Methods:

  • Systematic review of national and international clinical practice guidelines (CPGs).
  • Multi-stage cluster sampling of Australian pediatric care settings (2012-2013).
  • Medical record review by trained pediatric nurses to assess guideline adherence.

Main Results:

  • Ten antibiotic overuse indicators were identified across various pediatric conditions.
  • Overall compliance with guidelines was 61.9%, with significant variation by condition.
  • Low adherence (<50%) observed for asthma exacerbations, uncomplicated sore throats, and certain otitis media cases.

Conclusions:

  • Four candidate indicators (tonsillitis, otitis media, asthma) are proposed for monitoring.
  • These indicators can guide antimicrobial stewardship and clinical improvement initiatives.
  • Targeted interventions are needed to reduce inappropriate antibiotic prescribing in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
149
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
174
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
177
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Antibiotic Selection00:57

Antibiotic Selection

Overview
59.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
133